The Aquablation Robotic System is a cutting-edge treatment for benign prostate enlargement (BPE), recently recommended by the National Institute for Health and Care Excellence (NICE) and hailed for its groundbreaking approach. Troublesome urinary symptoms due to BPE affects over one third of men over the age of 50 in the UK, and is a growing health burden due to the aging population. 

The Aquablation unit offers non-thermal robotically executed therapy in a timely manner, offering significant symptom relief, with minimal risk and predictable outcomes. This therapy has a very favourable side-effect profile safeguarding both continence and sexual function. At Hampshire Hospitals, the adoption of Aquablation robotic therapy promises to greatly enhance the service we currently offer and is complimentary with the established prostate treatments, providing greater choice and improved outcomes for our patients.